Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. - Wikidata - awgldk - TriplyDB

Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.

Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.

http://www.wikidata.org/entity/Q34772619

about

Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia The Measurement of Reversible Redox Dependent Post-translational Modifications and Their Regulation of Mitochondrial and Skeletal Muscle Function A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions Mitochondrial morphology-emerging role in bioenergetics Sepsis-induced Cardiac Mitochondrial Damage and Potential Therapeutic Interventions in the Elderly Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention Somatic mutations in aging, cancer and neurodegeneration Mitochondrial dysfunction: different routes to Alzheimer's disease therapy Mitochondrial oxidative stress in aging and healthspan Quality control systems in cardiac aging Lessons from Microglia Aging for the Link between Inflammatory Bone Disorders and Alzheimer's Disease Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases Serendipity and the discovery of novel compounds that restore mitochondrial plasticity Resveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Aβ and Aβ-metal complexes toxicity Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline Efficient access to highly pure β-amyloid peptide by optimized solid-phase synthesis.Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Cyclophilin D Promotes Brain Mitochondrial F1FO ATP Synthase Dysfunction in Aging Mice.CART peptide is a potential endogenous antioxidant and preferentially localized in mitochondria.Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease.Toxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31.Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant Therapeutics Neuroprotective strategies involving ROS in Alzheimer disease.Mitochondria, Amyloid β, and Alzheimer's Disease Autophagy-mediated turnover of dynamin-related protein 1.Melatonin in mitochondrial dysfunction and related disorders Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage.Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.The role of mitochondrial DNA mutation on neurodegenerative diseases.Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.

P2860

Q21132375-1E52C0FD-7755-44DC-97BC-B7713AD697BF Q26774769-D60009A5-A2A7-4154-945E-B6F726DAF697 Q26781560-06E43425-1DB1-4006-9F59-3B5D1182FA75 Q26852770-EE898504-1637-4B30-BD46-3A3B55AE5B93 Q26853544-A2866408-2CE4-4F90-993A-602E55C4757E Q26859141-651FF148-F2C2-4FD6-8E54-B1FD31A44681 Q26865358-73E653D9-4207-4D19-889D-B30B1FF5ECDF Q27000745-5B3FA2C5-6F6C-425F-BC5A-F8F84A1FD6A1 Q27009475-6E8EA526-A3E0-4234-BE28-7DF0BB1F96A9 Q27025099-EBC35DA9-01A4-4091-A3E4-B1880C7E7633 Q28084341-C49AB348-A6B1-4590-AC2E-DD9C8B435679 Q28085613-5C9A6181-8765-4226-9595-E553432DD50C Q28114981-BEFCAA8A-CC84-48AA-9787-7BB5333F9EF1 Q28300234-096E1A21-82D9-47DE-9F92-C7541ADD80C0 Q28384256-4B12CA99-11D8-406A-896A-CDB7B1BA2A26 Q28478772-3971B852-5FB4-4436-8459-F40FA6C50EBA Q28486236-DE25C3CC-2943-41F0-85D0-01FA71426DE6 Q28730589-9878E0EA-9CCF-49B2-A16C-D1A0D7710F18 Q30476347-6F6B062F-E633-4825-A529-054E21ED5D5B Q31073092-787E3E61-BB2C-47D4-9F6E-D6937CFA3165 Q33556068-B80B388C-0E09-43F1-AE8E-EA5332C1C869 Q33585950-DA66C672-020E-40E0-9413-41A9997839C7 Q33783000-89D89B9D-D145-41F2-B16E-B6249CBB1593 Q33870189-AC085515-F631-47F4-80DF-4E697E3B96F6 Q34123653-D0AE3115-92F8-472A-A91B-68F4E5DA07F5 Q34299928-7D6781C2-4D41-4D21-9DEA-1538BE0BF3E6 Q34544243-74F86155-0875-4C4B-8C1F-7BC0992B88B4 Q34566188-C3B96193-C81A-4338-9FC6-9665DACCE268 Q34590202-7656D482-4377-4720-A5D2-935441397A06 Q34627072-2C516CDE-FCE1-4E97-940B-48A8F4FE9BDE Q34731547-B12474B2-2341-4184-9E59-B38414738DA3 Q34757939-EE04C7D8-41E6-435F-81E7-33FCA87D11DC Q34922777-BE0C5262-1C39-4B3D-BF4E-9B8D9A9AEB0B Q34927824-CF57E255-B468-437B-8A4F-FE21152492A5 Q35001051-8BE68DF5-9FA8-4B30-BAF0-2C102E69CFC2 Q35030813-1BB6FDBE-4D0B-4449-AE88-6C6A48ED055F Q35126945-D2719511-3007-4016-9579-39DB641FE434 Q35148462-982F53C5-FC50-4B37-9F5A-D16C4D6C4A19 Q35152954-E875703D-E2C9-4A94-8054-C9A165ECA2FB Q35256535-2C179E46-3A51-41B0-B8AA-2471248AA7C6

P2860

Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.

http://www.wikidata.org/entity/Q34772619

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Mitochondria-targeted antioxid ...... n Alzheimer's disease neurons.

@ast

Mitochondria-targeted antioxid ...... n Alzheimer's disease neurons.

@en

Mitochondria-targeted antioxid ...... n Alzheimer's disease neurons.

@nl

type

label

Mitochondria-targeted antioxid ...... n Alzheimer's disease neurons.

@ast

Mitochondria-targeted antioxid ...... n Alzheimer's disease neurons.

@en

Mitochondria-targeted antioxid ...... n Alzheimer's disease neurons.

@nl

prefLabel

Mitochondria-targeted antioxid ...... n Alzheimer's disease neurons.

@ast

Mitochondria-targeted antioxid ...... n Alzheimer's disease neurons.

@en

Mitochondria-targeted antioxid ...... n Alzheimer's disease neurons.

@nl

P1433

Q34772619-8A9F9E85-9948-418E-A938-BA24B6AF1275

P1476

Q34772619-69AD114B-0670-4951-A28A-908CBB8EF4CE

P2093

Q34772619-02B32C5C-99E0-463E-927B-CD51D145B76D

Q34772619-03BBE26E-EDAD-4DF1-8CDA-21116D13F4B9

Q34772619-1685F97B-0DEB-48EB-A98D-9337809D5E09

Q34772619-2A4781D6-BA5F-4EFC-8833-472F0A5A5295

Q34772619-594C2589-61FB-47EF-886A-CAC7B6C43BCD

Q34772619-7161DDFF-C9FA-4CA4-ACC4-794BE66A428F

Q34772619-7D8F6C23-CDDE-4E25-8D27-2DACE3E01328

Q34772619-850F70A1-1311-4144-B240-C7242F6AA946

Q34772619-F46DF441-D020-40D1-8EEB-6763B0945C2E

P2860

Q34772619-022BECD0-D948-4479-B6AD-EA299DDAD931

Q34772619-0D52F912-8E78-4BE2-9550-904F5AE3E7D6

Q34772619-1CCF6EDC-E2CA-4C61-8C12-B0003A843AFF

Q34772619-201D2637-FE4B-4C7D-BF29-35A69276C186

Q34772619-2D2DD2B3-1449-4DC8-A66A-A251EA46FBA1

Q34772619-34A2B112-D198-4956-8A91-640B7C32E0AD

Q34772619-35236AFE-3F97-4353-BB82-CFB2159105BA

Q34772619-3548C4CE-7415-4DE8-9635-683FDE33496E

Q34772619-39CC800D-0213-4687-9AAB-DDA1F7AF6F6B

Q34772619-465318FC-3E87-4823-92C1-828101B39F06

P304

Q34772619-1A5449A0-8DC2-42CD-949A-362E8967D3A1

P31

Q34772619-A5386961-EA39-4D19-B47E-603521E5ED7D

P356

Q34772619-DFB13A58-EFE9-42CE-8C87-EF2B610097D4

P478

Q34772619-A1F8DC88-05C7-471D-B420-533600AA369E

P577

Q34772619-E895D605-C8DE-4F49-AC57-E79486CC1B3C

P5875

Q34772619-AF0C2537-DF87-42C7-A3F5-975115B8E323

P698

Q34772619-8F301BC2-54C1-4283-9AFA-6FFC084A33AC

P921

Q34772619-4474A6D1-8FE1-4A51-B50B-2A75E21E9183

Q34772619-EBCE51C4-AC09-4121-BA9F-7309469CAAE5

P932

Q34772619-F9B9DE76-2590-4785-879F-9652417A94BC

P356

JAD-2010-100564

P1433

Journal of Alzheimer's Disease

P1476

Mitochondria-targeted antioxid ...... n Alzheimer's disease neurons.

@en

P2093

Anda Cornea

http://www.w3.org/2001/XMLSchema#string

Arubala P Reddy

http://www.w3.org/2001/XMLSchema#string

Byung Park

http://www.w3.org/2001/XMLSchema#string

Hazel H Szeto

http://www.w3.org/2001/XMLSchema#string

Marcus J Calkins

http://www.w3.org/2001/XMLSchema#string

Maria Manczak

http://www.w3.org/2001/XMLSchema#string

Michael P Murphy

http://www.w3.org/2001/XMLSchema#string

P Hemachandra Reddy

http://www.w3.org/2001/XMLSchema#string

Peizhong Mao

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Alzheimer's disease: genes, proteins, and therapy

Unified nomenclature for the winged helix/forkhead transcription factors

Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

PGC-1alpha: a key regulator of energy metabolism

Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model

NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth

P304

S609-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2010-100564

http://www.w3.org/2001/XMLSchema#string

P478

20 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44593000

http://www.w3.org/2001/XMLSchema#string

P698

20463406

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3072711

http://www.w3.org/2001/XMLSchema#string